Characterizing Pediatric Trauma Patients and EMS Agencies That Are Optimal Targets for Prehospital Pediatric Blood

Sriram Ramgopal1, Christian Martin-Gill2

  • 1Division of Emergency Medicine, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, Illinois.

Insights

Many injured children in the US are eligible for prehospital blood transfusions, but current use is low. Expanding access requires targeted programs for emergency medical services (EMS) agencies most likely to treat these pediatric trauma patients.

Area of Science:

  • Pediatric Trauma Care
  • Emergency Medical Services (EMS)
  • Blood Product Administration

Background:

  • Trauma is a significant cause of mortality in children within the United States.
  • Prehospital administration of blood products presents a critical intervention for severely injured pediatric patients.
  • Understanding the current landscape of prehospital care for injured children is essential for improving outcomes.

Purpose of the Study:

  • To determine the frequency with which injured children meet physiological criteria for prehospital blood transfusion.
  • To assess the utilization rates of prehospital blood products in this pediatric trauma population.
  • To identify characteristics of EMS agencies that could facilitate the implementation of expanded prehospital transfusion programs.

Main Methods:

  • Retrospective analysis of the 2021-2024 National Emergency Medical Services Information System (NEMSIS) datasets.
  • Inclusion criteria: children (<18 years) with documented injuries.
  • Eligibility criteria for transfusion: systolic blood pressure below the 5th centile for age with elevated heart rate, or systolic blood pressure below the 1st centile.

Main Results:

  • Over 2.4 million encounters yielded 34,221 (1.37%) children potentially eligible for blood transfusion.
  • Adolescents, falls, and motor vehicle collisions were common among eligible patients.
  • Blood products were administered in only 669 (0.027%) of all encounters and 1.01% of eligible encounters.
  • 1.4% of EMS agencies provided blood products to children, with 84.4% of eligible patients cared for by Advanced Life Support (ALS) agencies.
  • Agencies with higher service levels (ALS/critical care), rural locations, and specific organizational structures were more likely to treat eligible pediatric trauma patients.

Conclusions:

  • A substantial number of injured children in a national prehospital sample met criteria for blood transfusion eligibility.
  • Prehospital blood product administration for pediatric trauma remains uncommon and is influenced by system-level factors.
  • Expanding prehospital transfusion programs necessitates strategic implementation within EMS agencies best positioned to care for these patients, supported by appropriate equipment and protocols.
Abstract

Related Concept Videos

Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Blood Transfusion01:15

Blood Transfusion

Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...